Pharmacoeconomic guidelines for formulary submissions in managed care Newsletter Article 09 February 2013 Pages: 5 - 5
Blinding economic analyses alongside clinical trials Newsletter Article 09 February 2013 Pages: 6 - 6
Studies of inappropriate care - useful for cost containment? Newsletter Article 09 February 2013 Pages: 7 - 7
Interdisciplinary ciprofloxacin streamlining decreases costs Newsletter Article 09 February 2013 Pages: 7 - 7
Nonhospital costs of care for cystic fibrosis considerable Newsletter Article 09 February 2013 Pages: 7 - 7
US association releases erectile dysfunction treatment guidelines Newsletter Article 09 February 2013 Pages: 8 - 8
Benign prostatic hypertrophy - use of terazosin reduces cost Newsletter Article 09 February 2013 Pages: 8 - 8
Concerns raised about analgesic prescribing in South Africa Newsletter Article 09 February 2013 Pages: 9 - 9
Gemcitabine cost effective in non-small-cell lung cancer Newsletter Article 09 February 2013 Pages: 9 - 9
Economic impact of stroke after CABG surgery ‘excessive’ Newsletter Article 09 February 2013 Pages: 10 - 10
Dorzolamide vs pilocarpine in glaucoma - effects on QOL Newsletter Article 09 February 2013 Pages: 11 - 11